Readers should understand that compounded GLP-1 availability may depend on current federal policy, state rules, individual pharmacy requirements, current shortage status, and clinician judgment
Oral GLP-1s can produce an average weight loss of ~6%14%, depending on the medication: Rybelsus (semaglutide) produces nearly 6% weight loss in one year , according to a small study of adults with obesity
The numbers that propagated through every metabolic-research conversation: For context, the equivalent SURMOUNT-1 figure for tirzepatide 15 mg over a longer 72-week period was a 20.9 percent body-weight reduction
Since the expiry of the patent, several Indian drug makers have rolled out generic semaglutide products, with monthly injections costing anywhere between 1,300 rupees to 4,200 rupees (US$15-US$45)
It's definitely one of our more tolerable treatments